Sangamo Therapeutics, Inc. SGMOQ
0.14
(0.01)
(6.67%)
as of 25 Sep
- Market cap
- $41.9M
- P/E
- 0.0×
Follow SGMOQ
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/S ratio |
2.98 | 3.56 | 0.55 | 4.35 | 9.79 | 17.76 | 9.16 | 13.18 | 37.48 | 11.28 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.53 | 0.00 | 0.00 | 184.49 | 0.00 |
P/Operating CF |
(4.82) | (61.39) | (1.93) | (8.50) | (20.57) | (488.65) | (45.08) | (27.71) | (81.37) | (18.59) |
P/B ratio |
0.00 | 9.04 | 1.18 | 1.64 | 2.89 | 4.22 | 2.17 | 3.03 | 7.29 | 1.61 |
Price to Tangible BV |
0.00 | 0.00 | 3.12 | 2.34 | 3.85 | 5.29 | 2.76 | 4.08 | 7.36 | 1.62 |
EV/Sales |
3.33 | 3.44 | 0.29 | 2.21 | 6.79 | 12.66 | 6.02 | 8.77 | 31.50 | 4.13 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
(1.35) | (2.96) | (0.23) | (1.10) | (3.22) | 8.80 | (4.27) | 20.26 | 103.03 | (1.22) |
EV/FCF |
(1.34) | (2.73) | (0.21) | (1.01) | (2.93) | 9.64 | (3.74) | (113.65) | 155.06 | (1.20) |
Quick Ratio |
0.50 | 0.93 | 1.72 | 2.53 | 2.99 | 4.51 | 5.73 | 5.16 | 5.50 | 11.12 |
Current Ratio |
0.84 | 1.13 | 1.98 | 2.69 | 3.12 | 4.60 | 5.80 | 5.23 | 5.54 | 11.25 |
Net Debt/EBITDA |
0.18 | 0.44 | 0.49 | 1.31 | 2.04 | 5.15 | 3.20 | 4.62 | 3.94 | 1.94 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 6.93% | 6.10% | 4.09% | 6.46% | 4.69% | 8.63% | 2.50% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.13 | 0.12 | 0.08 | 0.10 | 0.08 | 0.13 | 0.03 |
Asset Turnover |
0.49 | 0.43 | 0.48 | 0.17 | 0.13 | 0.15 | 0.17 | 0.19 | 0.16 | 0.10 |
Operating CF/Net income |
0.79 | 0.69 | 0.87 | 1.16 | 1.31 | (1.40) | 1.52 | (0.53) | (0.20) | 0.92 |
Capex/Depreciation |
(0.01) | (0.03) | (0.19) | (1.04) | (1.14) | (1.17) | (4.22) | 12.41 | (4.55) | (0.60) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| (2,891.84%) | (185.39%) | (136.47%) | (57.37%) | (40.86%) | (26.02%) | (23.80%) | (24.62%) | (33.67%) | (43.61%) | |
| (152.35%) | (73.38%) | (70.85%) | (29.94%) | (21.47%) | (15.35%) | (15.50%) | (15.58%) | (24.55%) | (38.20%) | |
ROIC |
0.00% | 0.00% | (9,085.05%) | (223.40%) | (267.41%) | 0.00% | (58.98%) | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(2,790.10%) | (411.98%) | (350.93%) | (76.26%) | (55.30%) | (21.71%) | (26.04%) | (16.64%) | (23.26%) | (50.16%) |
Average Days of Receivables |
3.42 | 3.32 | 1.91 | 14.67 | 20.98 | 19.33 | 133.95 | 21.82 | 35.76 | 97.82 |
Research and Development Expense of Revenue |
284.87% | 192.94% | 132.81% | 224.53% | 208.51% | 152.84% | 142.46% | 136.01% | 179.75% | 338.43% |
Selling, General and Administrative Expense of Revenue |
88.20% | 77.38% | 34.71% | 56.32% | 57.11% | 56.77% | 60.22% | 55.34% | 74.38% | 135.80% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.16 | 0.13 | 0.11 | 0.15 | 0.16 | 0.01 | 0.01 |
Share Based Compensation of Revenue |
22.95% | 21.42% | 15.53% | 28.44% | 29.77% | 21.75% | 18.87% | 17.38% | 24.86% | 77.66% |
Graham Net Nets |
(0.32) | (0.13) | 0.12 | 0.07 | 0.05 | 0.10 | 0.21 | 0.17 | 0.11 | 0.58 |
Graham Number |
0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
(104.76%) | (50.00%) | (260.71%) | (39.81%) | (16.53%) | (5.96%) | (10.39%) | (6.18%) | (3.99%) | (32.90%) |
Free Cash Flow Yield |
(83.22%) | (35.40%) | (251.82%) | (50.30%) | (23.66%) | 7.39% | (17.59%) | (0.59%) | 0.54% | (30.46%) |
Revenue per Share |
0.14 | 0.29 | 1.01 | 0.72 | 0.77 | 0.88 | 0.91 | 0.87 | 0.47 | 0.27 |
Operating CF per Share |
(0.35) | (0.33) | (1.29) | (1.45) | (1.61) | 1.26 | (1.29) | 0.38 | 0.14 | (0.93) |
Capex per Share |
0.00 | 0.00 | (0.12) | (0.13) | (0.16) | (0.11) | (0.18) | (0.44) | (0.05) | (0.01) |
Free Cash Flow per Share |
(0.35) | (0.33) | (1.41) | (1.58) | (1.77) | 1.15 | (1.47) | (0.07) | 0.10 | (0.94) |
Cash per Share |
0.07 | 0.21 | 0.46 | 1.80 | 2.60 | 4.77 | 3.23 | 4.13 | 3.12 | 2.02 |
Shareholders Equity per Share |
(0.05) | 0.11 | 0.48 | 1.91 | 2.60 | 3.70 | 3.86 | 3.79 | 2.41 | 1.93 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
(0.05) | 0.11 | 0.48 | 1.91 | 2.60 | 3.70 | 3.86 | 3.79 | 2.41 | 1.93 |
Free Cash Flow |
(97.31) | (67.41) | (246.00) | (243.80) | (256.53) | 155.16 | (165.08) | (6.51) | 7.43 | (66.61) |
Working Capital |
(6.64) | 5.89 | 46.60 | 188.62 | 270.88 | 516.12 | 335.60 | 332.01 | 203.54 | 136.29 |
Capital Expenditures |
(0.10) | (0.27) | (21.15) | (20.17) | (23.28) | (14.71) | (20.67) | (43.06) | (3.75) | (0.73) |
Net Current Asset Value |
(38.18) | (27.17) | 11.90 | 32.78 | 52.19 | 218.48 | 200.70 | 187.38 | 149.56 | 127.88 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.12 | 0.18 | 0.21 | 0.12 | 0.20 | 0.51 | 0.10 | 0.04 |
Net Profit Margin |
(310.81%) | (169.45%) | (146.30%) | (172.76%) | (161.05%) | (102.37%) | (92.93%) | (80.91%) | (149.23%) | (369.58%) |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.69 | 0.52 | 4.07 | 0.30 | 0.40 | 0.30 | 0.16 | (0.04) | 0.03 | 0.19 |
Cash ROIC |
(1,620.51%) | (131.44%) | (153.59%) | (46.95%) | (35.78%) | 10.92% | (20.84%) | (5.30%) | (4.36%) | (25.63%) |
Accounts Receivable Turnover |
88.19 | 79.78 | 65.33 | 20.55 | 17.54 | 5.39 | 4.80 | 19.57 | 8.33 | 4.83 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
0.45 | 0.72 | 2.70 | 5.42 | 6.31 | 21.93 | 21.32 | 4.32 | 4.39 | 4.01 |
Average Payables |
14.96 | 15.37 | 18.84 | 16.09 | 11.16 | 9.61 | 14.06 | 16.25 | 8.65 | 7.25 |
Average Assets |
80.69 | 133.48 | 363.91 | 642.22 | 830.24 | 788.03 | 613.96 | 438.57 | 222.32 | 187.56 |
Average Common Equity |
4.25 | 52.83 | 188.92 | 335.15 | 436.35 | 465.05 | 400.00 | 277.58 | 162.05 | 164.32 |
Columns are period end dates